Received Aug 21, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| HEP | HEP B (RECOMBIVAX HB) | MERCK & CO. INC. | UNK | Y014090 | OT |
No adverse event; TE. RECOMBIVAX HB was administered to one patient; This spontaneous report was received from a Physician and refers to a patient of unknown age and gender. The patient's medical history, concurrent conditions and concomitant therapies were not reported. On 28-Jul-2025, the patient was vaccinated with Hepatitis B Vaccine (Recombinant) (RECOMBIVAX HB) 2.5/0.5 injection (lot #Y014090, expiration date: 01-Jun-2027) 0.5 mL administered by Unknown route as Prophylaxis. It was reported that the vaccine administered had a temperature excursion. No additional adverse events were reported.